Petra M. van Ham - Concepedia

Author

Petra M. van Ham

University Medical Center Utrecht

Also Known As

P. M. van Ham, P.M. van Ham, Petra M van Ham, Petra M. van Ham

Publications

729

Citations

H-Index

Concepts

All Affiliations

University Medical Center Utrecht Ghent University Hospital IrsiCaixa

About

Petra M. van Ham is an author at University Medical Center Utrecht specializing in primary immunodeficiency, epidemiology, and aids pathogenesis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	30
2	Epidemiology	1	1	30
3	Immunodeficiencies	1	1	30
4	Sexual Health	1	1	30
5	Aids Pathogenesis	1	1	30

Petra M. van Ham

Publications

727

Citations

H-Index

Page 1

	Year	Citations
CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections Ferdy R. van Diemen, Elisabeth Kruse, Marjolein J. G. Hooykaas, PLoS Pathogens	2016	286
A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape Robert Jan Lebbink, Dorien C. M. de Jong, Femke Wolters, Scientific Reports	2017	132
Primary resistance to integrase strand-transfer inhibitors in Europe: Table 1. María Casadellà, Petra M. van Ham, Marc Noguera-Julián, Journal of Antimicrobial Chemotherapy	2015	68
Comparison of digital PCR platforms and semi-nested qPCR as a tool to determine the size of the HIV reservoir Kobus J. Bosman, Monique Nijhuis, Petra M. van Ham, Scientific Reports	2015	60
Dependence on the CCR5 Coreceptor for Viral Replication Explains the Lack of Rebound of CXCR4-Predicted HIV Variants in the Berlin Patient Jori Symons, Linos Vandekerckhove, Gero Hütter, Clinical Infectious Diseases	2014	36
Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection Bridgette J. Connell, Lucas E. Hermans, Annemarie M. J. Wensing, Scientific Reports	2020	35
Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice Jori Symons, Linos Vandekerckhove, Roger Paredes, Clinical Microbiology and Infection Primary ImmunodeficiencySexual HealthEpidemiologyTreatment And PreventionHuman Retrovirus	2011	30
Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient Jori Symons, S.F.L. van Lelyveld, A. I. M. Hoepelman, Journal of Antimicrobial Chemotherapy	2011	29
Development of sensitive dd<scp>PCR</scp> assays to reliably quantify the proviral <scp>DNA</scp> reservoir in all common circulating <scp>HIV</scp> subtypes and recombinant forms Kobus J. Bosman, Annemarie M. J. Wensing, Aster E. Pijning, Journal of the International AIDS Society	2018	26
Impact of the HIV-1 env Genetic Context outside HR1–HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates Franky Baatz, Monique Nijhuis, Morgane Lemaire, PLoS ONE	2011	15

Page 1